- Home
- / Molecular Templates
Molecular Templates
Stock Price
$0.4
2024-10-29
Market Capitalization
$3.3 M
2024-10-29
Revenue
$57.3 M
FY, 2023
Molecular Templates Summary
Company Summary
- Overview
- Molecular Templates (MTEM) is a biopharmaceutical company focused on the discovery and development of differentiated, targeted, biologic therapeutics for cancer and other serious diseases. It develops a pipeline of therapies through its proprietary biologic-engineered toxin body (ETB) drug platform.
- Type
- Public
- Status
- Active
- Founded
- 2009
- HQ
- Austin, TX, US | view all locations
- Website
- https://www.mtem.com/
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
2 locations detected
Austin, TX HQ
United States
8900 Amberglen Blvd #300
New York, NY
United States
180 Varick St #510
Molecular Templates Financials
Summary Financials
- Revenue (Q2, 2024)
- $572.0K
- Net income (Q2, 2024)
- ($8.1M)
- Cash (Q2, 2024)
- $9.7M
- EBIT (Q2, 2024)
- ($8.3M)
- Enterprise value
- $2.0M